DUPONT CAPITAL MANAGEMENT CORP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$223,457
+80.2%
18,889
-9.7%
0.01%
+57.1%
Q3 2022$124,000
-80.1%
20,914
-55.9%
0.01%
-53.3%
Q2 2018$624,000
-24.8%
47,454
-18.8%
0.02%
-25.0%
Q1 2018$830,000
+55.7%
58,421
-10.1%
0.02%
+66.7%
Q4 2017$533,000
+75.3%
64,957
+153.1%
0.01%
+71.4%
Q3 2017$304,000
+17.8%
25,6620.0%0.01%
+16.7%
Q2 2017$258,00025,6620.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders